Charles Spicer

Charles Alexander Evan Spicer currently serves as Chairman-Product Development Awards Selection at the United Kingdom Department of Health & Social Care, Independent Non-Executive Chairman at EMV Capital Plc since 2023, Deputy Chairman at The Royal Humane Society, Chairman at Trust William Ltd., Chairman at Creo Medical Ltd., Non-Executive Chairman at Korn Wall Ltd., Non-Executive Director at The Fishmongers Co., Member at Health Innovation Challenge Fund, Operating & Advisory Partner at Gyrus Capital SA since 2019, and Advisor at Science Creates Ventures LLP.
Former roles include Chief Executive Officer at MDY Healthcare Ltd. from 2006 to 2009, Non-Executive Chairman at Realm Therapeutics Plc from 2014 to 2019, Non-Executive Chairman at 11 Health & Technologies Ltd., Non-Executive Chairman at Creo Medical Group Plc, Non-Executive Chairman at Ixico Plc from 2016 to 2024, Non-Executive Director at Aircraft Medical Ltd. from 2013 to 2015, Associate Director at Daniel Stewart & Co. Plc from 1989 to 1991, Independent Non-Executive Director at Ark Therapeutics Group Plc from 2012 to 2014, Non-Executive Director at Varex Imaging Sweden AB, Director at Stanmore Implants Worldwide Ltd. from 2008 to 2016, Director at Gresham's School, Senior Independent Director at MJ Hudson Group Plc in 2022, Head-Healthcare Corporate Finance at Numis Securities Ltd., Principal at Bear Stearns & Co. Ltd. from 1987 to 1989, Principal at City & Guilds Group from 2016 to 2021, and a position at Nomura International Plc in 2004.
Education includes graduation from the University of Cambridge and a doctorate from the University of London conferred in 2018.